Description

Almiba (L-carnitine) Oral Solution 120 ml Vial with Syringe

Ingredients

Active ingredient: L-carnitine

Dosage

Recommended dosage: Consult your healthcare provider for the appropriate dosage based on your condition.

Indications

Almiba oral solution is indicated for the treatment of L-carnitine deficiency and associated conditions.

Contraindications

Do not use Almiba oral solution if you are allergic to L-carnitine or any other ingredients in the product.

Directions

Shake well before use. Administer the prescribed dose using the provided syringe.

Scientific Evidence

L-carnitine plays a crucial role in energy production by facilitating the transport of fatty acids into the mitochondria for ATP generation. Research has shown that L-carnitine supplementation can improve exercise performance, muscle recovery, and symptoms of fatigue. A study published in the “Journal of Physiology” demonstrated that L-carnitine supplementation enhanced exercise capacity in individuals with L-carnitine deficiency.

Additional Information

• Storage: Store Almiba oral solution in a cool, dry place away from direct sunlight.
• Side effects: Common side effects may include nausea, vomiting, or diarrhea. Consult your doctor if any adverse reactions occur.

Pharmacological Effects: L-carnitine supplementation has been studied for its potential benefits in various conditions such as cardiovascular health, exercise performance, and cognitive function. It acts as a cofactor in fatty acid metabolism, aiding in the conversion of fats into energy. Additionally, L-carnitine exhibits antioxidant properties, protecting cells from oxidative damage.

Clinical Trials: Clinical trials have shown promising results regarding the efficacy of L-carnitine supplementation in improving symptoms of angina, heart failure, and peripheral vascular disease. A meta-analysis published in the “American Journal of Clinical Nutrition” concluded that L-carnitine supplementation significantly reduced markers of oxidative stress and inflammation in patients with cardiovascular diseases.